Related Experiment Videos
Preventing recurrent myocardial infarction. Use of calcium-channel blockers
1Baylor College of Medicine, Methodist Hospital, Houston, TX 77030.
Insights
Patients with non-Q-wave myocardial infarction face high reinfarction risks. Prophylactic diltiazem (Cardizem) significantly reduced early reinfarction and severe angina in these vulnerable patients.
Area of Science:
- Cardiology
- Clinical Medicine
Background:
- Non-Q-wave myocardial infarction (NQMI) patients have an 8% mortality rate within the first month.
- These patients exhibit high vulnerability to reinfarction and death during the first year post-MI.
- Cumulative injury from repeated NQMI episodes leads to survival rates similar to Q-wave infarction patients by two years.
Purpose of the Study:
- To evaluate the efficacy of prophylactic diltiazem in reducing early reinfarction and severe angina in NQMI patients.
Main Methods:
- Patients with NQMI were administered prophylactic diltiazem (Cardizem) 24 to 48 hours after hospital admission.
Main Results:
- Prophylactic diltiazem administration significantly reduced the incidence of early reinfarction.
- Diltiazem treatment also decreased the occurrence of severe angina in NQMI patients.
Conclusions:
- Early prophylactic diltiazem is an effective strategy for mitigating early reinfarction and severe angina in patients with non-Q-wave myocardial infarction.
- This intervention may improve outcomes for NQMI patients at high risk for subsequent cardiac events.
Abstract:
Although mortality in the first month after myocardial infarction is only 8% for patients who have non-Q-wave infarction, these patients are highly vulnerable to reinfarction and death throughout most of the first year. Repeated episodes of non-Q-wave infarction result in a cumulative amount of injury so that two years after the initial episode, survival rates of these patients are similar to those of patients with Q-wave infarction. Prophylactic diltiazem (Cardizem) given 24 to 48 hours after admission reduced the incidence of early reinfarction and severe angina in patients who had non-Q-wave infarction.